HRT Financial’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.39M Buy
299,736
+232,665
+347% +$6.55M 0.02% 856
2026
Q1
$1.91M Buy
+67,071
New +$2.29M ﹤0.01% 1649
2025
Q2
– Sell
-44,022
Closed -$1.42M – 2585
2025
Q1
$1.42M Sell
44,022
-4,531
-9% -$168K 0.01% 966
2024
Q4
$1.48M Buy
48,553
+567
+1% +$18.2K 0.01% 876
2024
Q3
$1.34M Buy
47,986
+18,692
+64% +$461K 0.01% 1075
2024
Q2
$667K Sell
29,294
-6,889
-19% -$159K ﹤0.01% 1174
2024
Q1
$1.1M Buy
36,183
+10,326
+40% +$346K 0.01% 842
2023
Q4
$922K Buy
+25,857
New +$962K 0.01% 1032
2023
Q2
– Sell
-78,800
Closed -$3.27M – 2448
2023
Q1
$3.27M Buy
78,800
+70,813
+887% +$2.94M 0.04% 400
2022
Q4
$354K Buy
+7,987
New +$334K 0.01% 1633
2022
Q1
– Sell
-15,944
Closed -$1.11M – 3073
2021
Q4
$1.11M Sell
15,944
-254
-2% -$18.5K 0.01% 1019
2021
Q3
$1.13M Buy
+16,198
New +$1.25M 0.01% 1151
2021
Q1
– Sell
-5,571
Closed -$310K – 2674
2020
Q4
$310K Sell
5,571
-2,297
-29% -$99.3K 0.01% 1269
2020
Q3
$313K Buy
+7,868
New +$334K 0.01% 1113
2019
Q2
– Sell
-8,805
Closed -$235K – 742
2019
Q1
$235K Buy
+8,805
New +$267K 0.04% 349

Other funds holding ATRC

HRT Financial's ATRC Position: Q2 2026 in Review

HRT Financial increased its AtriCure (ATRC) stake by 347% in Q2 2026, buying an estimated $6.55M and bringing the position to 299,736 shares worth $8.39M. The position accounts for 0.02% of the portfolio, ranked #856.

HRT Financial first reported a position in ATRC in Q1 2019 and has held it in 15 quarters since. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • HRT Financial held 299,736 shares of AtriCure worth $8.39M as of Q2 2026.
  • HRT Financial bought 232,665 AtriCure shares in Q2 2026, an estimated $6.55M.
  • AtriCure made up 0.02% of HRT Financial's portfolio in Q2 2026, its #856 holding.
  • HRT Financial first reported a position in AtriCure in Q1 2019 and has held it in 15 quarters since.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.